跳至主要内容
临床试验/NCT07190807
NCT07190807招募中不适用

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control (MOSAIC Study)

Boston Scientific Corporation7 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年11月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
70
试验地点
7
主要终点
Targeted Pain Responder Rate

研究概览

简要总结

Study to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU).

In addition, to compile real-world clinical outcomes in subjects with chronic, intractable low back and/or leg pain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Persistent spinal pain syndrome (PSPS) Type I (or non-surgical refractory back pain), or PSPS Type II (Failed Back Surgery Syndrome, FBSS) diagnosis.
  • •Diagnosed with chronic pain of the trunk and/or limbs for at least 6 months.
  • •18 years of age or older when written informed consent is obtained
  • •Able to independently read and complete all questionnaires and assessments provided in English.
  • •Signed a valid, IRB or EC approved informed consent form (ICF) provided in English.

排除标准

  • •Any pain-related diagnosis, medical or psychological condition that, in the Investigator's judgment might confound reporting of study outcomes (e.g., vascular or neurogenic claudication, osteoarthritis, plantar fasciitis, pelvic pain, anginal pain, chronic migraine, acute herniated disc, malignancy, untreated major depression, injury claim).
  • •Significant cognitive impairment at Screening and Baseline visit that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
  • •A female who is pregnant, lactating, or is of childbearing potential and planning to get pregnant during the study or not using adequate contraception.
  • •Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study.

研究组 & 干预措施

Time Varied Pulse (TVP)-SCS settings

Experimental

干预措施: Boston Scientific WaveWriter Alpha™ SCS Systems (Device)

结局指标

主要结局

Targeted Pain Responder Rate

时间窗: 3 months post-activation

Proportion of subjects with 50% or greater reduction from Baseline Visit in average targeted pain intensity at 3 months post-activation

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验